RECOMBINA Competitors and Similar CompaniesClear all
Thousand Oaks Biopharmaceuticals's competitors and similar companies include ReCode Therapeutics.
 Thousand Oaks Biopharmaceuticals Thousand Oaks Biopharmaceuticals (澳斯康生物制药) is a company that provides contract research and manufacturing services with a focus on cell line development. |  ReCode Therapeutics ReCode Therapeutics is a company developing non-viral nanoparticles for delivery of diverse RNA- and protein-based therapeutics to targeted tissues, and tRNA NanoCorrectors. | |
Founding Date | Founding Date 2017 | Founding Date 2015 |
Type | Type Private | Type Private |
Tags | ||
Locations | Locations Nantong, CN HQ | Locations Menlo Park, US HQ |
Employees | Employees 43 | Employees 1062% decrease |
Funding | ||
Latest funding round | Latest funding round $ 64m (almost 6 years ago) | Latest funding round $ 80m (about 6 years ago) |
Total funding raised | Total funding raised $ 107.6m | Total funding raised $ 82m |
For sources of this data, please see the company profile
View Company Profiles
ReCode Therapeutics
HQ
Menlo Park, US
Employees
106↓ 2% decrease
ReCode Therapeutics is a company developing non-viral nanoparticles for delivery of diverse RNA- and protein-based therapeutics to targeted tissues, and tRNA NanoCorrectors.
View company